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http://www.hqlo.com/content/12/1/38RESEARCH Open AccessProperties of patient-reported outcome measures
in individuals following acute whiplash injury
Joshua Pink1*, Stavros Petrou1, Esther Williamson2, Mark Williams2 and Sarah E Lamb2Abstract
Background: The aim of this study was to assess the acceptability, reliability, validity and responsiveness of the
Short-Form Health Survey (SF-12) and its preference-based derivative (SF-6D), the EQ-5D and the Neck Disability
Index (NDI) in patients recovering from acute whiplash injury.
Methods: Data from the Managing Injuries of the Neck Trial of 3,851 patients with acute whiplash injury formed
the basis of this empirical investigation. The EQ-5D and SF-12 were collected at baseline, and all three outcome
measures were then collected at 4 months, 8 months and 12 months post-randomisation. The measures were
assessed for their acceptability (response rates), internal consistency, validity (known groups validity and discriminant
validity) and their internal and external responsiveness.
Results: Response rates were broadly similar across the measures, with evidence of a floor effect for the NDI and a
ceiling effect for the EQ-5D utility measure. All measures had Cronbach’s α statistics of greater than 0.7, indicating
acceptable internal consistency. The NDI and EQ-5D utility score correlated more strongly with the physical component
scale of the SF-12 than the mental component scale, whilst this was reversed for the SF-6D utility score. The smaller
standard deviations in SF-6D utility scores meant there were larger effect sizes for differences in utility score between
patients with different injury severity at baseline than for the EQ-5D utility measure. However, the EQ-5D utility measure
and NDI were both more responsive to longitudinal changes in health status than the SF-6D.
Conclusions: There was no evidence of differences between the EQ-5D utility measure and NDI in terms of their
construct validity, discriminant validity or responsiveness in patients with acute whiplash injury. However, both
demonstrated superior responsiveness to longitudinal health changes than the SF-6D.
Keywords: Whiplash, Outcome assessment, Quality of life, Health statusIntroduction
Whiplash injuries are soft tissue injuries of the neck that
result from an acceleration-deceleration energy transfer
mechanism. The prevalence of whiplash injuries is high
and is increasing worldwide, particularly within devel-
oped countries [1]. Within the United Kingdom (UK)
alone the incidence of whiplash injuries is suggested to
be around 400,000 per year [1], with the Association of
British Insurers noting a 25% rise in whiplash claims
during 2002–2008 [1]. Approximately 30-50% of people
suffering whiplash injuries report chronic symptoms [2],
with an annual cost to the UK economy in 2002 of over
£3.1 billion, made up primarily of health service costs and* Correspondence: j.pink@warwick.ac.uk
1Warwick Clinical Trials Unit, Division of Health Sciences, Warwick Medical
School, University of Warwick, Coventry CV4 7AL, UK
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reproduction in any medium, provided the orproductivity losses [3]. Various treatments for whiplash
associated disorders have been proposed, including
advice, active management consultations and physiother-
apy sessions, but there has been a lack of evidence for
both the effectiveness and cost-effectiveness of these
interventions [4]. The Managing Injuries of the Neck
Trial (MINT) was conducted to fill some of the gaps in
this evidence base [5].
Patient reported outcome (PRO) instruments can be
used to measure the effects of whiplash injuries in terms
of health-related quality of life (HRQoL), and measure
the benefits of interventions aimed at their prevention
or alleviation. However, there is currently a paucity of
evidence on the measurement properties of these in-
struments when completed by individuals with whiplash
injuries. Patient-reported outcome measures (PROMs). This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Pink et al. Health and Quality of Life Outcomes 2014, 12:38 Page 2 of 12
http://www.hqlo.com/content/12/1/38are increasingly important outputs for randomised con-
trolled trials [6], as they provide a scientifically robust way
of reflecting the patient perspective in the assessment
process [7]. Moreover, trial-based economic evaluations
are often reliant on preference-based PROMs to calculate
the HRQoL component of the quality-adjusted life-year
(QALY) metric. Health and Care Excellence (NICE) in
England and Wales, for economic evaluations [8].
With the increasing need for quantitative assessment
of the impact of preventive or treatment interventions, it
is important to identify appropriate outcome measures
for use in patients with whiplash injuries. Furthermore,
these measures should ideally possess properties, such as
internal consistency and construct validity, that satisfy
broader regulatory and reimbursement requirements [9].
The MINT study included two generic instruments, the
Short-Form Health Survey version 1 (SF-12) [10] and
the preference-based EQ-5D-3 L [11], and one neck injury
specific measure, the Neck Disability Index (NDI) [12].
Generic instruments are designed to be applicable across
a range of health conditions and patient populations, and
can be useful to detect unexpected outcomes or side-effects
of interventions, which may not be picked up by condition
specific measures designed to capture the predicted health
status changes. Conversely, more narrowly targeted condi-
tion specific measures can provide outputs with a greater
clinical relevance, and are often associated with an in-
creased responsiveness compared to generic measures [13].
These differing properties have led to the recommendation
for the joint use of generic and condition specific measures
in clinical trials [7].
This study compares the three different measures
listed above, all of which are commonly used in whiplash
injury trials, in terms of their acceptability, reliability,
validity and responsiveness in patients with whiplash
injuries [14,15].
Methods
Study population
Data for this study were drawn from MINT, a pragmatic,
cluster randomised controlled trial that recruited patients
with acute whiplash injury from 15 NHS emergency
departments in the UK [5]. To be eligible for inclusion,
patients needed to have a whiplash associated disorder
of grades I-III [16]. Patients younger than 18 years of age,
with a non-transient loss of consciousness, a Glasgow
Coma Score of 12 or less, fractures or dislocations of
the spine or other bones, requiring inpatient admission
or having a severe psychiatric illness, were excluded. The
centres were randomised to provide either active manage-
ment (including The Whiplash Book [17]) or usual care.
Patients with substantial symptoms persisting beyond
3 weeks were eligible for further individual randomisation
to either a single or six physiotherapy sessions. Since inthis study we are primarily interested in the properties of
the outcome measures used within MINT, rather than any
evaluation of the interventions in the trial, all MINT
participants were included in these analyses, regardless
of trial allocation.
Patients who consented to be part of the MINT study
at the emergency departments were sent an information
letter and questionnaires to complete within three days
of attendance, including the SF-12 and EQ-5D health
outcome measures. These data, which are used as baseline
measurements for the analysis, were returned an average
of two weeks post emergency department attendance.
Further data was collected by postal questionnaires at 4,
8 and 12 months after the initial emergency department
attendance, with SF-12 and EQ-5D data, as well as the
NDI, collected at each of these time points. On each
follow-up occasion, patients failing to respond within a
week were sent a second questionnaire and reminder
letter, with those still not responding within a further week
called twice over the telephone in an attempt to obtain
the core MINT outcome measures (NDI and EQ-5D).
Data collection instruments
The SF-12 consists of 12 questions with a one week recall
period measuring various aspects of physical and mental
health, from which three summary scores can be extracted.
The Physical Component Summary Score (PCS) and Men-
tal Component Summary Score (MCS) are both standar-
dised to have a mean of 50 and a standard deviation of 10
[18], whilst a six dimension health-state classification based
on the SF-12, called the SF-6D, can also be constructed,
containing 7,500 potential health states with utility values,
calculated using the standard gamble technique, ranging
from 0.345 to 1 [19].
The EQ-5D contains six items, and asks people about
their health state on the day they complete the question-
naire. The first five items ask the respondent to describe
their mobility, self-care, usual activities, pain/discomfort
and anxiety/depression in the form of a health state classifi-
cation system. Responses to each of these five dimensions
are divided into three ordinal levels coded: (1) no problems;
(2) some or moderate problems; and (3) severe or extreme
problems. A total of 243 (35) health states are generated
by the EQ-5D descriptive system. Responses to the five
item descriptive system can be converted into utility
scores using a UK specific tariff [20], calculated from a
time trade-off study, taking values between −0.59 and 1,
with 1 corresponding to “perfect health” and 0 represent-
ing a health state considered to be equivalent to death
[11]. The sixth item of the EQ-5D consists of a visual
analogue scale (VAS) and asks people to rate their current
overall health on a scale from 0 (the worst health state
they can imagine) to 100 (the best health state they can
imagine).
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pain-related activity restrictions, with each item scored
on a scale from 0 (no restriction) to 5 (severe restriction).
These scores are then summed to give a total score
ranging from 0 to 50 then doubled to scale to a score from
0 to 100. Vernon et al. have published a categorisation for
these NDI scores, with a total score of 4 or less corre-
sponding to no disability, 5–14 mild disability, 15–24
moderate disability, 25–34 severe disability and greater
than 34 complete disability [12]. These categorisations
are now a commonly used approach in analyses making
use of the NDI [21].
Statistical analysis
The MINT study contained no specific questions looking
at the acceptability of the different outcome measures
used, and no information was collected on the reasons
for missing data where a particular questionnaire was
returned, but not all items within it were completed.
Therefore, the acceptability of the measures (EQ-5D
(utility), EQ-5D (VAS), SF-6D, SF-12(PCS), SF-12(MCS)
and NDI) was assessed by looking at the response rates to
each measure at each time point of assessment, as well
as the individual item and dimension completion rates
[22]. Whilst this will provide less information than
would have been available if patients had been directly
questioned [23], there is evidence of a link between re-
sponse rates and acceptability of a questionnaire to re-
spondents [24,25].
The internal consistency of the EQ-5D(utility), SF-6D
and NDI, that is, the extent to which multiple items in
each scale measure the same underlying concept, was
assessed by calculating Cronbach’s α coefficients [26].
This has also often been used, in the absence of any
better method, as a proxy for the overall reliability of
the instrument, that is, the stability and consistency of
the concept being measured. Whilst there are ques-
tions as to how relevant a concept internal consistency
is for preference-based measures [22], an established
convention has been to deem a score of ≥0.70 to be
sufficient for use in research, and a score of ≥0.90 for
broader use in routine clinical practice [25]. It would
be expected that the NDI, since it covers a narrower
range of outcomes than the EQ-5D and SF-6D, would
have the highest Cronbach’s α.
The construct validity of the measures was assessed in
terms of both known groups validity and discriminant
validity [14]. In known groups validity, we take pre-
specified groups where we would expect there to be a
difference in health status, and thus instrument scores.
The different scores between groups for alternative
measures can then be compared to see if there is a pattern
in the sensitivity to these expected differences [26]. We
classified patients according to whiplash associated disorder(WAD) grades at baseline, and performed independent
samples t-tests for differences in baseline EQ-5D(utility),
EQ-5D(VAS), SF-6D, SF-12(PCS) and SF-12(MCS) scores,
or differences in NDI at 4 months, the latter measure not
having been included at baseline. The magnitude of these
differences was compared by calculating effect sizes, i.e.
the mean difference between the WAD grade groups
(either WAD grade 1 versus WAD grade 2 or WAD grade
1 versus WAD grade 3) standardised by dividing by the
pooled standard deviation of the two groups. This stand-
ardisation allows for the unbiased comparison of measures
with differing scales [27]. A standard, if again largely arbi-
trary, classification system devised by Cohen regards an
effect size of 0.20 as small, 0.50 as moderate and 0.80 or
greater as large [27].
Discriminant validity, the extent to which different
instruments with overlapping constructs converge or
diverge, was tested by calculating Pearson’s correlation
coefficients and Spearman’s rank correlation coefficients
between each of the summary scores of the EQ-5D, SF-6D
and NDI. A higher correlation between one of the two
utility measures and the NDI cannot interpreted as evi-
dence of superiority in psychometric terms over the other
utility measure (the NDI cannot be regarded as a gold
standard and generic, preference based measures are not
intended to measure the same constructs as condition
specific measures [22]). Nevertheless, it could be regarded
as evidence of a greater degree of construct overlap between
that utility measure and the NDI. Spearman’s correlations
were also calculated for the individual items within and
between each measurement, with the assumption being
that similar dimensions in different measures should
correlate more highly than different dimensions within
the same measure.
We assessed both the internal and external responsive-
ness of the EQ-5D(utility), SF-6D and NDI. The internal
responsiveness of a measure represents its ability to detect
changes over a specified timeframe [28]. We calculated
effect sizes (the mean change in measure over time divided
by the standard deviation pooled across the two time
points) and standardised response means (these differ
from effect sizes as they are standardised by dividing by
the standard deviation of the difference between the
measures at the two time points) for the changes in each
measure over time, together with the associated 95%
confidence intervals [29]. We also calculated the propor-
tion of patients in floor (the lowest possible) or ceiling
(the highest possible) health states at each time point, as a
high proportion of individuals at one end of the scale can
indicate a lack of specificity in that region as well as a lack
of responsiveness to change.
External responsiveness considers whether the changes
registered by a measure over time correspond to those
expected based on an external reference measure of health
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measure two different aspects of responsiveness, respon-
siveness to self-reported changes in neck injury status and
responsiveness to changes in NDI score. Firstly, we used a
question asked to the patient at each follow-up point
as to whether their neck injury was much worse, worse,
the same, better or much better than at the time of com-
pletion of the previous questionnaire. Mean differences,
standardised response means and effect sizes were calcu-
lated for the changes in outcome measures for patients in
each of these self-reported groups. A more responsive
measure should show larger differences between the
self-reported groups. Secondly, we used various categori-
sations of the NDI as our reference measure, to see which
of the utility measures, EQ-5D or SF-6D, better captured
changes in neck disability. The NDI categorisations used
were: change in NDI score between 4 months and
12 months, change in Vernon category between 4 months
and 12 months, 4 month Vernon categories, 12 month
Vernon categories and finally a categorisation of patient
outcome trajectories defined by Sterling et al., where neck
injuries are classed as either mild, moderate or chronic-
severe [30]. These trajectories had been constructed from
a previous data set of 155 individuals monitored for one
year post whiplash injury [30].
Analysis was carried out using SPSS version 21 [31]
and R version 2.15.1 [32].
Results
3,851 individuals were randomised in MINT, 1,006 of
whom were complete responders, that is, they returned
the SF-12 and EQ-5D measures at baseline, 4 months,Table 1 Baseline characteristics of the MINT study population
Whole population (n = 3,851) Comp
Age: mean (SD) 36.98 (13.42)
Sex:
% male 1661/3851 (43.1%)
% female 2133/3851 (55.4%)
Treatment group step 1:
% usual care 1598/3851 (41.5%)
% active management 2253/3851 (58.5%)
Treatment group step 2*:
% advice 287/574 (50%)
% physiotherapy 287/574 (50%)
Initial pain intensity: mean (SD) 5.13 (1.89)
WAD grade at presentation:
% grade 1 2088/3851 (54.2%)
% grade 2 1659/3851 (43.1%)
% grade 3 104/3851 (2.7%)
The percentages may not add up to 100% due to missing data. *The denominators8 months and 12 months and the NDI at 4 months,
8 months and 12 months. The baseline characteristics
of the whole population and of complete versus non-
compete responders are given in Table 1. There were sig-
nificant differences (at the 95% level) between responders
and non-responders in all the characteristics examined,
with the exception of WAD grade at baseline [5]. Complete
responders tended to be older, and were more likely to be
female, with lower pain intensity at baseline. Response rates
were also higher from people randomised to the control
group (at either randomisation) than those assigned to the
MINT interventions.
Acceptability
Table 2 shows the response rates (assessed in terms of
complete responses to all relevant questions) for each of
the measures. Baseline response rates varied from 78.6%
(the SF-6D subset of the SF-12) to 89.1% (EQ-5D utility),
whilst response rates at the end of the follow-up period
varied from 50.4%-69.2%. There were very low rates (<2%)
of partial completion (defined as failure to complete at
least one item) across measures and follow-up points, with
individuals tending to either complete the whole measure
or not respond at all.
Reliability
Cronbach’s alpha scores were 0.790, 0.871 and 0.922 for
the EQ-5D(utility), SF-6D and NDI, respectively, all
above the threshold of 0.70 recommended for broader
use in clinical research. The Cronbach’s alpha score for
the NDI was also above the 0.90 cut-off recommended
for use in routine clinical practice. A higher value wouldlete responders (n = 1,006) Non-complete responders (n = 2,845)
37.91 (12.44) 36.65 (13.74)
385/1006 (38.3%) 1276/2845 (44.9%)
614/1006 (61.0%) 1519/2845 (53.4%)
452/1006 (44.9%) 1146/2845 (40.3%)
554/1006 (55.1%) 1699/2845 (59.7%)
103/198 (55.1%) 184/376 (48.9%)
95/198 (44.9%) 192/376 (51.1%)
4.79 (1.78) 5.25 (1.92)
557/1006 (55.4%) 1531/2845 (53.8%)
424/1006 (42.1%) 1235/2845 (43.4%)
25/1006 (2.5%) 79/2845 (2.8%)
are lower here as not all participants were randomised at step 2.
Table 2 Response rates to each measure over time; % of non-missing data by questionnaire and time point
(sample size of 3,851 in all cases)
Baseline 4 months 8 months 12 months Complete responders (all time points)
EQ-5D (utility) 89.1% 78.4% 70.2% 69.2% 49.7%
EQ-5D (VAS) 87.3% 76.5% 68.9% 67.7% 46.9%
SF-6D* 78.6% 63.7% 55.5% 51.3% 30.3%
SF-12 (PCS) 79.9% 62.5% 55.1% 50.4% 30.0%
SF-12 (MCS) 79.9% 62.5% 55.1% 50.4% 30.0%
NDI N/A 76.9% 69.4% 68.5% 51.9%
*The SF-6D was regarded as complete if there were sufficient items to calculate a utility score.
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of impacts it aims to capture.
Validity
Descriptive statistics for each of the measures at baseline
are shown in Table 3 (with the exception of the NDI for
which descriptive statistics at the 4 month follow-up are
presented). There is some evidence of a floor effect (scores
of 0) with the NDI and a ceiling effect (scores of 1) with
the EQ-5D utility measure, but no measure has more than
11.5% of scores at either extreme of a scale. The results of
tests of known groups validity summarised in Table 4
show that there were differences in scores for all measures
at baseline between pre-specified WAD groups (1 versus 2
and 1 versus 3). All differences are statistically significant
at the 5% level between WAD grades 1 and 2. The small
number of individuals in WAD grade 3 (n = 104) meant
that only the EQ-5D(VAS), SF-6D and SF-12(MCS)
differences are significant between WAD grades 1 and
3, despite the magnitude of the differences being larger
in all cases than those observed for WAD grades 1 ver-
sus 2. The SF-6D had larger effect sizes than the EQ-5D
utility measure across both comparisons (grade 1 versus
grade 2 and grade 1 versus grade 3), though they both fall
into the small-moderate range as defined by the Cohen
classifications. Specifically, the effect sizes for the EQ-5D
and SF-6D, respectively, were 0.310 and 0.364 between
grades 1 and 2, and 0.353 and 0.496 between grades 1
and 3.
Table 5 shows the correlation coefficients between the
various summary measures, with all correlations statisticallyTable 3 Descriptive statistics for measures (baseline data with
Outcome range N
EQ-5D (utility) −0.594 to 1 3430 0
EQ-5D (VAS) 0 to 100 3361 6
SF-6D 0.41 to 1 3027 0
SF-12 (PCS)* 15.42 to 65.92 3076
SF-12 (MCS)* 9.51 to 68.21 3076 4
NDI 0 to 96 2963 2
*The PCS and MCS are standardised to have a mean of 50 and a SD of 10 in the gesignificant at the 1% level. The SF-6D correlates more
strongly with the mental component scale (rather than the
physical component scale) of the SF-12, whilst the EQ-5D
(both utility and VAS measures) and NDI correlate more
strongly with the physical component scale, with the
NDI being more strongly correlated with the EQ-5D
utility measure than the SF-6D. Individual item correlations
followed the expected patterns (i.e. significant positive
correlations between worsening health states on all items
within and between the SF-6D, EQ-5D utility and NDI
measures) with a smallest correlation coefficient of 0.202
(between the self-care dimension from the EQ-5D and the
mental health dimension from the SF-6D). Dimensions
measuring similar constructs also correlated more highly
than others with, as an example, the pain questions on
each measure all having correlations of greater than 0.615
between one another.
Responsiveness
Tables 6, 7 and 8 display measures of the responsiveness
of the EQ-5D(utility), SF-6D and NDI, respectively, using
self-reported change in neck injury as the referent. Tables 9
and 10 display similar results for the EQ-5D(utility) and
SF-6D, but using the NDI as the referent. In Table 6, when
data were combined across all possible time points of
comparison, there were statistically significant differences
in changes in EQ-5D utility scores between alternative cat-
egories of self-reported neck injury, ranging from a change
of −0.2961 for patients reporting their injury had got
much worse to a change of 0.0955 for those reporting
it had got much better. This was also the case for thethe exception of the NDI (4 months))
Mean (SD) Median Floor Ceiling
.587 (0.298) 0.689 0.1% 8.3%
3.67 (19.96) 65.0 0.1% 0.8%
.647 (0.136) 0.615 0% 0.7%
40.26 (8.98) 39.16 0% 0%
0.80 (12.80) 40.25 0% 0%
1.03 (17.45) 18.0 11.5% 0%
neral population.
Table 4 Known groups validity effect sizes (baseline data with the exception of the NDI (4 months))
WAD grade 1 WAD grade 2 Difference
(95% confidence interval)
Effect size for group 1 vs group 2
(95% confidence interval)
EQ-5D (utility) 0.684 (0.235) 0.606 (0.272) 0.078 (0.045, 0.110) 0.310 (0.184, 0.437)
EQ-5D (VAS) 68.84 (18.23) 63.80 (18.55) 5.04 (2.72, 7.36) 0.274 (0.147, 0.401)
SF-6D 0.680 (0.143) 0.630 (0.130) 0.050 (0.032, 0.067) 0.364 (0.237, 0.491)
SF-12 (PCS) 42.41 (9.24) 39.41 (8.83) 3.01 (1.84, 4.17) 0.331 (0.204, 0.458)
SF-12 (MCS) 44.04 (11.97) 41.42 (12.15) 2.62 (1.07, 4.17) 0.217 (0.090, 0.344)
NDI 15.64 (14.21) 20.03 (15.22) −4.39 (−6.24, −2.54) −0.300 (−0.427, −0.173)
WAD grade 1 WAD grade 3 Difference
(95% confidence interval)
Effect size for group 1 vs group 3
(95% confidence interval)
EQ-5D (utility) 0.684 (0.235) 0.600 (0.300) 0.083 (−0.042, 0.209) 0.353 (−0.048, 0.754)
EQ-5D (VAS) 68.84 (18.23) 59.60 (20.92) 9.24 (1.88, 16.61) 0.508 (0.106, 0.910)
SF-6D 0.680 (0.143) 0.609 (0.149) 0.070 (0.129, 0.128) 0.496 (0.094, 0.897)
SF-12 (PCS) 42.41 (9.24) 39.14 (9.87) 3.28 (−0.45, 7.00) 0.353 (−0.048, 0.754)
SF-12 (MCS) 44.04 (11.97) 38.48 (12.57) 5.56 (0.74, 10.38) 0.463 (0.061, 0.864)
NDI 15.64 (14.21) 22.89 (19.30) −7.25 (−15.29, 0.79) −0.503 (−0.905, −0.101)
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change in utility score between the better (0.0643) and
much better (0.0613) self-reported categories, which went
in the reverse order to that which would be expected.
Effect sizes and standardised response means were con-
sistently larger for the EQ-5D(utility) than for the SF-6D
(by an average of 49.8%), and were also consistently or-
dered across self-reported categories for the EQ-5D utility
measure, which was not the case for the SF-6D. There
was no consistent pattern of differences between the
EQ-5D(utility) and NDI, with effect sizes differing by a
smaller average of 16.9%. Furthermore, there was a con-
sistent pattern across all three measures for individuals
reporting that their neck injury was the same as 4 months
previously, with all showing (when time points were
pooled) a small improvement in score.
For the analyses using NDI categorisations as reference
categories, summarised in Tables 9 and 10, both the
EQ-5D(utility) and the SF-6D were consistently more
responsive when a longitudinal reference category was
used, that is, the referent was delineated as a change in a
measure rather than a value at a given time point. WhilstTable 5 Pearson’s (top-right) and Spearman’s (bottom-left) co
Pearson (TR)/Intra-class (BL) correlations EQ-5D (utility) EQ-5
EQ-5D (utility) N/A 0
EQ-5D (VAS) 0.694
SF-6D 0.774 0
SF-12 (PCS) 0.732 0
SF-12 (MCS) 0.621 0
NDI −0.792 −
Time points were combined and missing data excluded pairwise for each comparis
*p values were less than 0.001 for all correlations in this table.there was considerable variability between effect sizes and
standardised response means based on the reference
category used, the EQ-5D utility measure again came
out as consistently more responsive than the SF-6D (effect
sizes and standardised response means were respectively,
on average, 22.5% and 13.1% higher for the EQ-5D utility
measure than for the SF-6D).
Discussion
The intention of this study was to compare the properties
of different patient-reported outcome measures that have
been used following acute whiplash injury. The results
show significant variation between instrument properties
(known groups discrimination, responsiveness etc.) when
used in this population.
When comparing different patient-reported outcome
measures, there are a number of specific difficulties with
interpretation that it is important to note [33]. First, the
underlying concepts and domains of health measured
will not be the same with, in our case, the EQ-5D and
SF-12 being generic health measures whilst the NDI is
neck-injury specific. They also relate to different timerrelations between measures
D (VAS) SF-6D SF-12 (PCS) SF-12 (MCS) NDI
.676 0.691 0.663 0.601 −0.762
N/A 0.671 0.609 0.610 −0.628
.690 N/A 0.683 0.801 −0.714
.616 0.672 N/A 0.298 −0.771
.612 0.807 0.299 N/A −0.504
0.600 −0.693 −0.759 −0.464 N/A
on.
Table 6 Responsiveness of the EQ-5D over time, anchored by self-reported change in neck injury
T0 T1 Δ SRM (95% CI) ES (95% CI) n
EQ-5D utility baseline to 4 months with anchor of neck injury change baseline to 4 months
Much worse 0.7363 0.3253 −0.4110 −1.0516 (−2.4740, 0.4861) −1.9282 (−3.9172, 0.1913) 3
Worse 0.4838 0.5172 0.0334 0.1408 (−0.2908, 0.5690) 0.1077 (−0.4983, 0.7123) 21
Same 0.5731 0.6784 0.1053 0.4001 (0.2303, 0.5686) 0.4059 (0.1730, 0.6381) 145
Better 0.6162 0.7634 0.1473 0.6028 (0.4999, 0.7051) 0.7225 (0.5845, 0.8601) 431
Much better 0.7306 0.8898 0.1592 0.7998 (0.6846, 0.9142) 0.8748 (0.7267, 1.0224) 385
EQ-5D utility 4 months to 8 months with anchor of neck injury change 4 months to 8 months
Much worse N/A N/A N/A N/A N/A 0
Worse 0.7302 0.6754 −0.0549 −0.2346 (−0.5145, 0.0476) −0.2668 (−0.6599, 0.1276) 50
Same 0.8060 0.8102 0.0042 0.0294 (−0.0886, 0.1474) 0.0198 (−0.1471, 0.1866) 276
Better 0.7417 0.7919 0.0502 0.2692 (0.1611, 0.3769) 0.2698 (0.1191, 0.4203) 342
Much better 0.8492 0.9310 0.0818 0.5271 (0.4092, 0.6442) 0.5530 (0.3942, 0.7114) 317
EQ-5D utility 8 months to 12 months with anchor of neck injury change 8 months to 12 months
Much worse 0.6516 0.4704 −0.1812 −0.7190 (−1.6866, 0.3129) −0.4700 (−1.7162, 0.8041) 5
Worse 0.7499 0.6484 −0.1016 −0.4224 (−0.6872, −0.1543) −0.4723 (−0.8372, −0.1054) 59
Same 0.8474 0.8460 −0.0014 −0.0089 (−0.1122, 0.0944) −0.0070 (−0.1531, 0.1391) 360
Better 0.7889 0.8377 0.0489 0.2847 (0.1634, 0.4055) 0.2638 (0.0952, 0.4322) 273
Much better 0.8868 0.9324 0.0456 0.3195 (0.2008, 0.4376) 0.2957 (0.1313, 0.4598) 288
EQ-5D utility: above three combined
Much worse 0.6940 0.3979 −0.2961 −0.9696 (−1.8010, −0.0944) −0.8376 (−1.8512, 0.2030) 8
Worse 0.6546 0.6136 −0.0410 −0.1728 (−0.3457, 0.0007) −0.1788 (−0.4222, 0.0650) 130
Same 0.7422 0.7782 0.0360 0.2034 (0.1325, 0.2742) 0.1661 (0.0667, 0.2654) 781
Better 0.7156 0.7977 0.0821 0.3930 (0.3300, 0.4558) 0.4226 (0.3359, 0.5092) 1046
Much better 0.8222 0.9177 0.0955 0.5605 (0.4934, 0.6274) 0.5815 (0.4915, 0.6714) 990
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http://www.hqlo.com/content/12/1/38periods, with the EQ-5D asking specifically about an indi-
vidual’s health ‘today’, the version of the SF-12 in MINT
using a one-week recall period and the NDI asking about
current capabilities without specifying a time frame. Scales
and the outcome space of possible answers also differ,
a problem that can be partially, though not entirely, ad-
dressed by standardisation (i.e. effect sizes or standardised
response means), and the directions of values for better
health are not always the same, with higher NDI scores
corresponding to worse health, the reverse being the case
for the other measures. When considering effect sizes and
standardised response means, it is important to remember
that differences between measures can be driven by
differences in magnitude, differences in variability or
both, which can make interpretations of these statistics
more difficult.
With all these provisos taken into account, there was
little evidence of differences in response or completion
rates between the different measures. Whilst there were
higher response rates to the EQ-5D and NDI as opposed
to the SF-12 this can be explained, at least in part, by
the follow-up methodology within MINT (missing EQ-5Dand NDI questionnaires were chased by postal reminders
and telephone contacts, whilst missing SF-12 question-
naires were chased by postal reminders only). There were
no meaningful differences if response rates were com-
pared prior to the additional telephone contacts. In the
postal questionnaires, the NDI was presented as the first
question, the SF-12 the second and the EQ-5D the third,
meaning that if questionnaire length is leading to partici-
pant fatigue and subsequent non-completion, we would
expect higher response rates to the NDI than the EQ-5D.
However, we in fact find the reverse pattern, with very
slightly (though non-significantly) higher response rates to
the EQ-5D.
The EQ-5D(utility) and NDI both appear to be more
responsive to longitudinal changes in health status than
the SF-6D and give results consistent with the expected
trend of deteriorating health status resulting in lower
utility values (EQ-5D) or increasing scores (NDI), whilst
the SF-6D does not. The EQ-5D(utility) correlates more
strongly with the NDI than the SF-6D does, perhaps im-
plying a higher level of construct overlap, and both the
EQ-5D(utility) and NDI correlate more strongly with
Table 8 Responsiveness of the NDI over time, anchored by self-reported change in neck injury
T0 T1 Δ SRM (95% CI) ES (95% CI) n
NDI 4 months to 8 months with anchor of neck injury change 4 months to 8 months
Much worse N/A N/A N/A N/A N/A 0
Worse 23.764 29.804 6.040 0.5816 (0.2790, 0.8791) 0.4163 (0.0190, 0.8116) 50
Same 16.031 15.753 −0.560 −0.0735 (−0.1916, 0.0447) −0.0336 (−0.2004, 0.1333) 276
Better 22.030 16.853 −5.446 −0.5521 (−0.6655, −0.4380) −0.4129 (−0.5642, −0.2613) 342
Much better 11.212 4.775 −6.439 −0.7657 (−0.8904, −0.6400) −0.7691 (−0.9302, −0.6075) 317
NDI 8 months to 12 months with anchor of neck injury change 8 months to 12 months
Much worse 34.800 47.600 12.800 0.9257 (−0.1823, 1.9635) 0.5261 (−0.7546, 1.7759) 5
Worse 21.653 27.792 6.139 0.6321 (0.3500, 0.9096) 0.4117 (0.0461, 0.7755) 59
Same 13.269 13.155 −0.114 −0.0179 (−0.1212, 0.0854) −0.0075 (−0.1536, 0.1386) 360
Better 16.921 12.897 −4.024 −0.5046 (−0.6302, −0.3782) −0.3391 (−0.5079, −0.1700) 273
Much better 7.873 4.192 −3.681 −0.6068 (−0.7320, −0.4807) −0.4831 (−0.6486, −0.3172) 288
NDI: above two combined
Much worse 34.800 47.600 12.800 0.9257 (−0.1823, 1.9635) 0.5261 (−0.7546, 1.7759) 5
Worse 22.709 28.799 6.090 0.6074 (0.4018, 0.8106) 0.4134 (0.1446, 0.6813) 109
Same 14.650 14.454 −0.337 −0.0486 (−0.1263, 0.0292) −0.0213 (−0.1312, 0.0886) 636
Better 19.476 14.875 −4.735 −0.5218 (−0.6059, −0.4374) −0.3752 (−0.5879, −0.3752) 615
Much better 9.543 4.484 −5.060 −0.6850 (−0.7733, −0.5962) −0.6307 (−0.7460, −0.5151) 605
Table 7 Responsiveness of the SF-6D over time, anchored by self-reported change in neck injury
T0 T1 Δ SRM (95% CI) ES (95% CI) n
SF-6D baseline to 4 months with anchor of neck injury change baseline to 4 months
Much worse 0.6800 0.6963 0.0163 0.1023 (−1.0446, 1.2261) 0.2037 (−1.4145, 1.7977) 3
Worse 0.6032 0.6165 0.0132 0.0836 (−0.3459, 0.5110) 0.1063 (−0.4997, 0.7109) 21
Same 0.6335 0.7019 0.0683 0.5939 (0.4164, 0.7696) 0.4961 (0.2620, 0.7294) 145
Better 0.6252 0.7628 0.1376 0.9996 (0.8836, 1.1148) 1.1166 (0.9728, 1.2599) 431
Much better 0.7085 0.8343 0.1257 0.8401 (0.7235, 0.9559) 0.9636 (0.8141, 1.1126) 385
SF-6D 4 months to 8 months with anchor of neck injury change 4 months to 8 months
Much worse N/A N/A N/A N/A N/A 0
Worse 0.7413 0.6979 −0.0434 −0.3673 (−0.6521, −0.0790) 0.1433 (−0.2496, 0.5354) 50
Same 0.7687 0.7836 0.0149 0.1355 (0.0169, 0.2539) 0.1401 (−0.0270, 0.3071) 276
Better 0.7498 0.7872 0.0374 0.3429 (0.2336, 0.4517) 0.1243 (−0.0258, 0.2743) 342
Much better 0.8237 0.8619 0.0382 0.3385 (0.2250, 0.4514) 0.1129 (−0.0429, 0.2687 317
SF-6D 8 months to 12 months with anchor of neck injury change 8 months to 12 months
Much worse 0.6425 0.6035 −0.0390 −0.2883 (−1.1694, 0.6256) −0.3175 (−1.5569, 0.9411) 5
Worse 0.7387 0.6905 −0.0482 −0.3272 (−0.5879, −0.0639) −0.3707 (−0.7339,-0.0059) 59
Same 0.8078 0.8086 0.0008 0.0080 (−0.0953, 0.1113) 0.0059 (−0.1402, 0.1520) 360
Better 0.7804 0.7983 0.0178 0.1757 (0.0560, 0.2951) 0.1461 (−0.0219, 0.3140) 273
Much better 0.8435 0.8634 0.0199 0.2027 (0.0859, 0.3192) 0.1802 (0.0165, 0.3438) 288
SF-6D: above three combined
Much worse 0.6613 0.6499 −0.0114 −0.0789 (−0.7703, 0.6180) −0.1028 (−1.0817, 0.8797) 8
Worse 0.6944 0.6683 −0.0261 −0.1885 (−0.3616, −0.0147) −0.1941 (−0.4376, 0.0498) 130
Same 0.7367 0.7647 0.0280 0.2627 (0.1913, 0.3340) 0.2039 (0.1044, 0.3033) 781
Better 0.7185 0.7828 0.0643 0.5360 (0.4711, 0.6007) 0.5215 (0.4343, 0.6086) 1046
Much better 0.7919 0.8532 0.0613 0.4907 (0.4247, 0.5565) 0.5124 (0.4228, 0.6019) 990
Pink et al. Health and Quality of Life Outcomes 2014, 12:38 Page 8 of 12
http://www.hqlo.com/content/12/1/38
Table 9 Responsiveness of the EQ-5D to changes between 4 and 12 months, anchored by NDI classifications
T0 T1 Δ SRM (95% CI) ES (95% CI) n
EQ-5D utility changes based on NDI score changes
Decrease 0.7563 0.8639 0.1076 0.6034 (0.5211, 0.6854) 0.5890 (0.4798, 0.6980) 673
No change 0.9215 0.9267 0.0053 0.0465 (−0.0958, 0.1887) 0.0381 (−0.1630, 0.2392) 190
Increase 0.7872 0.7526 −0.3145 −1.7008 (−1.9078, −1.4921) −1.4186 (−1.6280, −1.2078) 218
EQ-5D utility changes based on Vernon category changes
Decrease 0.7121 0.8706 0.1585 0.8649 (0.7452, 0.9838) 0.8734 (0.7225, 1.0238) 371
No change 0.8412 0.8662 0.0250 0.1780 (0.0993, 0.2566) 0.1420 (0.0315, 0.2525) 631
Increase 0.7682 0.6588 −0.1094 −0.4952 (−0.7275, −0.2600) −0.4259 (−0.7406, −0.1098) 79
EQ-5D utility changes based on 4 month Vernon categories
None 0.9431 0.9392 0.0061 0.0505 (−0.0509, 0.1519) 0.0545 (−0.0889, 0.1978) 374
Mild 0.7682 0.8570 0.0888 0.5061 (0.4107, 0.6010) 0.6156 (0.4858, 0.7451) 479
Moderate 0.6375 0.7174 0.0798 0.3444 (0.1972, 0.4907) 0.4195 (0.2154, 0.6231) 189
Severe 0.3879 0.5329 0.1451 0.4987 (0.1488, 0.8423) 0.4964 (0.0255, 0.9639) 36
Complete 0.1783 0.4307 0.2523 0.9407 (−0.5358, 2.2996) 1.5170 (−0.4398, 3.3493) 3
EQ-5D utility changes based on 12 month Vernon categories
None 0.8712 0.9563 0.0851 0.5622 (0.4752, 0.6488) 0.6759 (0.5584, 0.7931) 590
Mild 0.7364 0.7848 0.0484 0.2643 (0.1561, 0.3701) 0.3179 (0.1695, 0.4660) 354
Moderate 0.6325 0.6218 −0.0106 −0.0442 (−0.2239, 0.1357) −0.0489 (−0.3030, 0.2053) 119
Severe 0.3964 0.3452 −0.0512 −0.1335 (−0.6573, 0.3953) −0.1995 (−0.9404, 0.5452) 14
Complete 0.0300 0.1683 0.1383 1.4385 (−0.0687, 2.8662) 0.5549 (−0.8860, 1.9529) 4
EQ-5D utility changes based on stirling trajectories
Mild 0.8488 0.9090 0.0602 0.3913 (0.3201, 0.4623) 0.4292 (0.3311, 0.5272) 818
Moderate 0.6383 0.7819 0.1436 0.6822 (0.4871, 0.8751) 0.8367 (0.5783, 1.0935) 126
Chronic-severe 0.5908 0.5803 −0.0104 −0.0408 (−0.2082, 0.1268) −0.0418 (−0.2786, 0.1951) 137
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case for the SF-6D. The low level of correlation between
the MCS and PCS scales of the SF-12 (0.298, the lowest
between any two measures) indicates that these constructs
are indeed non-overlapping to a considerable extent.
In contrast, the SF-6D produces larger effect sizes
for differences in injury severity (WAD grade) than the
EQ-5D utility measure at a fixed time point. This may,
however, be driven by the lower standard deviation for
SF-6D values (in turn driven, at least in part, by the
lower possible range of outcome values) rather than
larger differences between the groups themselves. Indeed,
the differences in mean utility values between the groups
are again larger for the EQ-5D utility measure than for the
SF-6D. The SF-6D does have the advantage of showing no
discernible floor or ceiling effects, in contrast to both the
NDI and EQ-5D utility measure. The EQ-5D-5 L, a modi-
fication of the standard EQ-5D that provides five response
levels in each dimension, should help to address this issue,
but it is not yet in widespread use [34].
In order to try and understand the reasons for these
differences, it is important to consider both the descriptivesystems of the instruments and, for preference based
measures, the valuation methods [22], and there are
marked differences between the SF-6D and EQ-5D in
both these areas [35]. The SF-6D has more levels than
the EQ-5D, and is more concentrated on milder health
problems, with the worst states in the SF-6D descriptive
system arguably less severe than those in the EQ-5D de-
scriptive system [35,36]. There is evidence that the SF-6D
is better able to detect small changes in health, and is
more sensitive to changes in health status at the top end
of the distribution, whilst the EQ-5D is more sensitive to
health change in individuals with poor baseline health
[35]. There are also differences in the valuation method,
with the EQ-5D valued using the time-trade off approach
and the SF-6D valued using the standard gamble approach.
There is empirical evidence that the time-trade off ap-
proach results in higher values for milder states and
lower values for more severe states, which can thus
partially account for the greater range of index values
for the EQ-5D [36].
The fact that utility scores appear to change over time,
when patients report that their neck injury is the same, is
Table 10 Responsiveness of the SF-6D to changes between 4 and 12 months, anchored by NDI classifications
T0 T1 Δ SRM (95% CI) ES (95% CI) n
SF-6D changes based on NDI score changes
Decrease 0.7592 0.8200 0.0608 0.5328 90.4519, 0.6134) 0.4813 (0.3728, 0.5896) 673
No change 0.8523 0.8674 0.0152 0.1884 (0.0447, 0.3316) 0.1386 (−0.0628, 0.3398) 190
Increase 0.7656 0.7406 −0.0250 −0.2221 (−0.3562, −0.0875) −0.1854 (−0.3734, 0.0028) 218
SF-6D changes based on Vernon category changes
Decrease 0.7412 0.8189 0.0777 0.6508 (0.5384, 0.7625) 0.6096 (0.4622, 0.7566) 371
No change 0.8019 0.8219 0.0201 0.1975 (0.1186, 0.2762) 0.1593 (0.0487, 0.2698) 631
Increase 0.7444 0.7052 −0.0392 −0.3482 (−0.5743, −0.1200) −0.2858 (−0.5988, 0.0281) 79
SF-6D changes based on 4 month Vernon categories
None 0.8594 0.8730 0.0136 0.1482 (0.0462, 0.2500) 0.1445 (0.0009, 0.2880) 374
Mild 0.7827 0.8161 0.0344 0.2878 (0.1963, 0.3790) 0.2922 (0.1648, 0.4194) 479
Moderate 0.6437 0.7202 0.0766 0.5699 (0.4155, 0.7230) 0.6665 (0.4589, 0.8732) 189
Severe 0.5638 0.6408 0.0770 0.6503 (0.2863, 1.0067) 0.7700 (0.2882, 1.2466) 36
Complete 0.5018 0.5150 0.0132 0.1982 (−0.9695, 1.3221) 0.2469 (−1.3765, 1.8411) 3
SF-6D changes based on 12 month Vernon categories
None 0.8333 0.8733 0.0400 0.3844 (0.3006, 0.4679) 0.4019 (0.2866, 0.5171) 590
Mild 0.7378 0.7768 0.0389 0.3096 (0.2027, 0.4160) 0.3293 (0.1809, 0.4775) 354
Moderate 0.6490 0.6552 0.0062 0.0497 (−0.1302, 0.2294) 0.0544 (−0.1998, 0.3085) 119
Severe 0.5615 0.5666 0.0051 0.0538 (−0.4714, 0.5770) 0.0836 (−0.6583, 0.8239) 14
Complete 0.4669 0.5034 0.0365 1.9333 (0.1445, 3.6664) 2.3982 (0.4331, 4.2670) 4
SF-6D changes based on stirling trajectories
Mild 0.8197 0.8485 0.0288 0.2746 (0.2047, 0.3443) 0.2689 (0.1715, 0.3662) 818
Moderate 0.6530 0.7633 0.1103 0.8241 (0.6206, 1.0251) 0.9941 (0.7314, 1.2551) 126
Chronic-severe 0.6348 0.6417 0.0070 0.0583 (−0.1094, 0.2258) 0.0612 (−0.1757, 0.2980) 137
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subjective views and expectations change over time, causing
a drift in the outcome score [37]. However, we have no
evidence that this is more pronounced in one measure.
There are specific tests available to assess whether this
utility drift is actually the result of a response shift, rather
than simply measurement error, such as a then-test, where
patients are asked to retrospectively recall their health sta-
tus (as they now perceive it) at a previous time point, and
these are compared to the answers they gave at that time
point itself [38]. However, such data were not available
from the MINT study so no such test could be performed.
This study was helped by having access to a large cohort
of patients with whiplash associated disorders, in contrast
to many studies looking at the properties of instruments
that have much smaller sample sizes. The collection of
data at four separate time points is also an advantage over
simply having two data points per individual. However,
since the data used came from a clinical trial, all the usual
caveats apply about the differences between trials and
clinical practice, and the possibility for this to bias results,
though since this was a pragmatic trial this should haveless of an effect than in other situations [39]. Further, the
lack of NDI data at baseline is a substantial limitation,
making comparison between the NDI and other measures
much more problematic than for those where we have
contemporaneous data. There is also a concern due to the
large amount of missing data in the study (less than 50%
of participants returned questionnaires at all 4 time
points), which could introduce bias. However, these re-
sponse rates were similar to those for patient-reported
outcome measures in other trials looking at whiplash
interventions [40,41].
In conclusion, the evidence suggests that, for whiplash
studies where only one generic health outcome measure
is to be included, the EQ-5D is likely to offer advantages
over the SF-12 and its preference-based derivative (SF-6D).
Whilst this is the first study to look specifically at whiplash
injuries, the finding that the EQ-5D and SF-6D do not
provide interchangeable utility values, and that the EQ-5D
is likely to have advantages over the SF-6D, is supported
by other studies looking at neck injuries [42]. Comparisons
with the NDI are more difficult, as there may be particular
reasons for incorporating a condition-specific measure as
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disorders, whilst conversely the EQ-5D has the advantage
of being preference-based, and can thus be used in cost-
utility evaluations. Previous studies have shown the NDI
to have good internal consistency, test-retest reliability
and responsiveness [12,43]. Nevertheless, we found little
evidence for better performance by the NDI when com-
pared with the EQ-5D.
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